2025
Outcomes of Mechanical Thrombectomy for Acute Limb Ischemia at a Tertiary Referral Center
Loh S, Nasir A, Strosberg D, Ochoa Chaar C, Guzman R, Tonnessen B. Outcomes of Mechanical Thrombectomy for Acute Limb Ischemia at a Tertiary Referral Center. Journal Of Vascular Surgery 2025 PMID: 40024380, DOI: 10.1016/j.jvs.2025.02.027.Peer-Reviewed Original ResearchTertiary referral centerAcute limb ischemiaAdverse cardiovascular eventsReferral centerMechanical thrombectomyOpen surgeryThirty-dayCardiovascular eventsConversion to open surgeryLimb ischemiaTreated with mechanical thrombectomyMedian follow-upCatheter-directed thrombolysisManagement of acute limb ischemiaDuration of symptomsThirty-day complicationsOutcomes of mechanical thrombectomyRisk of limb lossHigh risk of limb lossAcute limb ischemia casesMechanical thrombectomy devicesBleeding eventsMulticenter trialThrombosed bypassesThrombosed stent
2024
Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences With Establishing an Institutional Cancer Registry
Yibrehu B, Mohammed T, Murthy S, Aderibigbe A, Daramola O, Arije O, Owoade I, Wuraola F, Olasehinde O, Betiku O, Folorunso S, Omoyiola O, Aderounmu A, Adisa A, Kingham P, Alatise O. Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences With Establishing an Institutional Cancer Registry. Journal Of Surgical Oncology 2024 PMID: 39558548, DOI: 10.1002/jso.27993.Peer-Reviewed Original ResearchInstitutional cancer registryGastric cancerCancer RegistryTreatment modalitiesSuspected gastric cancerManagement of gastric cancerQuality of registry dataTertiary referral centerGastric cancer registryHigh-risk patientsDatabase of patientsGastric cancer databasePeriodic chart reviewMetastatic diseaseAdvanced diseaseReferral centerCancer DatabaseAvailability of robust dataMedian timeChart reviewFollow-upDeadly malignancyBlood workPatientsRegistry dataP27.10.B FACTORS INFLUENCING TIMELY DIAGNOSIS IN NEUROLYMPHOMATOSIS
Doubrovinskaia S, Egert A, Karschnia P, Scheffler G, Huttner A, Fulbright R, Baehring J, Kaulen L. P27.10.B FACTORS INFLUENCING TIMELY DIAGNOSIS IN NEUROLYMPHOMATOSIS. Neuro-Oncology 2024, 26: v138-v139. PMCID: PMC11485484, DOI: 10.1093/neuonc/noae144.472.Peer-Reviewed Original ResearchNon-Hodgkin's lymphomaPeripheral nervous systemNerve root lesionsDiagnostic intervalRelapse of NHLSymptom onsetAssociated with early diagnosisTertiary referral centerAtypical clinical presentationRoot lesionsCerebrospinal fluid examinationDiagnostic work-upYale Cancer CenterPainful polyneuropathyAsymmetric neuropathyClinical presentationReferral centerFluid examinationQuality control databaseDiagnostic delayFDG-PETPrimary diseaseUnivariate analysisConventional CTNeurolymphomatosisEIF1AX mutation in thyroid nodules: a histopathologic analysis of 56 cases in the context of institutional practices
Abi-Raad R, Xu B, Gilani S, Ghossein R, Prasad M. EIF1AX mutation in thyroid nodules: a histopathologic analysis of 56 cases in the context of institutional practices. Virchows Archiv 2024, 485: 859-867. PMID: 39225726, PMCID: PMC11912518, DOI: 10.1007/s00428-024-03914-5.Peer-Reviewed Original ResearchFollicular nodular diseaseAnaplastic thyroid carcinomaPapillary thyroid carcinomaEIF1AX mutationsBenign thyroid nodulesThyroid carcinomaThyroid nodulesOncocytic adenomasMolecular alterationsGenetic abnormalitiesNon-invasive follicular thyroid neoplasmPapillary-like nuclear featuresAssociated with malignant tumorsWHO 5th EditionCancer referral centerFollicular thyroid neoplasmTertiary care hospitalOncocytic carcinomaThyroid neoplasmsReferral centerNodular diseasePathological diagnosisCancer Genome AtlasMalignant tumorsEIF1AXCochlear Apex Triangulation Utilizing Ct Measures And Middle Ear Landmarks
Cottrell J, Landsberger D, Breen M, Lebowitz J, Hagiwara M, Moonis G, Shapiro W, Friedmann D, Jethanamest D, McMenomey S, Roland J. Cochlear Apex Triangulation Utilizing Ct Measures And Middle Ear Landmarks. Otology & Neurotology Open 2024, 4: e060-e060. PMID: 39328867, PMCID: PMC11424059, DOI: 10.1097/ono.0000000000000060.Peer-Reviewed Original ResearchCochlear apexRound windowCochlear implant recipientsCochleariform processTemporal bone CT scansComputed tomographyMiddle ear landmarksImplant recipientsPreoperative computed tomographyTertiary referral centerSurgically relevant landmarksSuperior-inferior distanceImprove procedural successReferral centerSurgical approachCT scanOval windowAnteroposterior distanceMultiplanar reformattingCT measurementsCritical structuresReduce traumaSurrounding structuresPromontory boneElectrode placementComparison of organ involvement clusters in Black and White American sarcoidosis patients from a prospectively collected patient registry
Harper L, Tauquir A, Huang S, Wang X, Schupp J, Baughman R, Culver D. Comparison of organ involvement clusters in Black and White American sarcoidosis patients from a prospectively collected patient registry. Respiratory Medicine 2024, 226: 107605. PMID: 38537782, PMCID: PMC11840713, DOI: 10.1016/j.rmed.2024.107605.Peer-Reviewed Original ResearchPrevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients
Kotsiou O, Kirgou P, Tzouvelekis A, Kolilekas L, Manali E, Papiris S, Papakosta D, Antoniou K, Papanikolaou I, Steiropoulos P, Tomos I, Karampitsakos T, Levounets A, Fouka E, Spyropoulos G, Mastrodimou S, Papaioannou O, Kallieri M, Kosmidou N, Bizymi N, Zikos N, Dimeas I, Malli F, Daniil Z. Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients. Sarcoidosis, Vasculitis, And Diffuse Lung Diseases 2024, 41: e2024055. PMID: 39655591, PMCID: PMC11708959, DOI: 10.36141/svdld.v41i4.15661.Peer-Reviewed Original ResearchPET-CT findingsSarcoidosis patientsLikelihood of infectionInterstitial lung disease referral centersICU admissionPrevalence of SARS-CoV-2Younger ageSARS-CoV-2National multicenter studyGeneral populationInfection rateSARS-CoV-2 infectionPrevalence of SARS-CoV-2 infectionAdditional immunosuppressionCorticosteroid treatmentReferral centerMulticenter studySarcoidosisPatientsImmunosuppressionChance of infectionLonger diagnosisInfectionHospitalPrevalence
2023
Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists
Shah H, Shah R, Lockwood D, Yang N, Rohrbaugh T, Rutter M, Maurrasse S. Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists. The Laryngoscope 2023, 134: 2922-2930. PMID: 38149706, DOI: 10.1002/lary.31211.Peer-Reviewed Original ResearchLabel usePediatric otolaryngologistsAdverse eventsCommon indicationMost common indicationTertiary referral centerMultivariate logistic regressionPediatric Otolaryngology (ASPO) membersNational trendsCross-sectional surveyDexamethasone useReferral centerComplete responseChildren's HospitalSafety profileUnivariate analysisChoanal atresiaTracheal granulationAnecdotal successLogistic regressionOtolaryngologistsPractice typeEase of accessCPD usePrivate practiceAssessment of Required Patient Travel to Receive Interventional Radiology Services in the Resource-Limited Setting of Tanzania
Alswang J, Mbuguje E, Naif A, Musa B, Laage Gaupp F, Ramalingam V. Assessment of Required Patient Travel to Receive Interventional Radiology Services in the Resource-Limited Setting of Tanzania. Journal Of Vascular And Interventional Radiology 2023, 34: 2213-2217. PMID: 37619942, DOI: 10.1016/j.jvir.2023.08.008.Peer-Reviewed Original ResearchPrevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
Erickson P, Simrén J, Brum W, Ennis G, Kollmorgen G, Suridjan I, Langhough R, Jonaitis E, Van Hulle C, Betthauser T, Carlsson C, Asthana S, Ashton N, Johnson S, Shaw L, Blennow K, Andreasson U, Bendlin B, Zetterberg H, Weiner M, Aisen P, Petersen R, Jack C, Jagust W, Trojanowki J, Toga A, Beckett L, Green R, Saykin A, Morris J, Shaw L, Liu E, Montine T, Thomas R, Donohue M, Walter S, Gessert D, Sather T, Jiminez G, Harvey D, Bernstein M, Fox N, Thompson P, Schuff N, DeCArli C, Borowski B, Gunter J, Senjem M, Vemuri P, Jones D, Kantarci K, Ward C, Koeppe R, Foster N, Reiman E, Chen K, Mathis C, Landau S, Cairns N, Householder E, Taylor Reinwald L, Lee V, Korecka M, Figurski M, Crawford K, Neu S, Foroud T, Potkin S, Shen L, Kelley F, Kim S, Nho K, Kachaturian Z, Frank R, J Snyder P, Molchan S, Kaye J, Quinn J, Lind B, Carter R, Dolen S, Schneider L, Pawluczyk S, Beccera M, Teodoro L, M Spann B, Brewer J, Vanderswag H, Fleisher A, Heidebrink J, Lord J, Mason S, Albers C, Knopman D, Johnson K, Doody R, Villanueva Meyer J, Chowdhury M, Rountree S, Dang M, Stern Y, Honig L, Bell K, Ances B, Morris J, Carroll M, Leon S, Mintun M, Schneider S, OliverNG A, Griffith R, Clark D, Geldmacher D, Brockington J, Roberson E, Grossman H, Mitsis E, deToledo-Morrell L, Shah R, Duara R, Varon D, Greig M, Roberts P, Albert M, Onyike C, D’Agostino D, Kielb S, Galvin J, Pogorelec D, Cerbone B, Michel C, Rusinek H, de Leon M, Glodzik L, De Santi S, Murali Doraiswamy P, R Petrella J, Z Wong T, E Arnold S, H Karlawish J, Wolk D, D Smith C, Jicha G, Hardy P, Sinha P, Oates E, Conrad G, Lopez O, Oakley M, Simpson D, Porsteinsson A, Goldstein B, Martin K, Makino K, Saleem Ismail M, Brand C, Mulnard R, Thai G, Mc Adams Ortiz C, Womack K, Mathews D, Quiceno M, Diaz Arrastia R, King R, Weiner M, Martin Cook K, DeVous M, Levey A, Lah J, Cellar J, Burns J, Anderson H, Swerdlow R, Apostolova L, Tingus K, Woo E, Silverman D, Lu P, Bartzokis G, Graff Radford N, ParfittH F, Kendall T, Johnson H, Farlow M, Marie Hake A, Matthews B, Herring S, Hunt C, van Dyck C, Carson R, MacAvoy M, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Yuek Robin Hsiung G, Feldman H, Mudge B, Assaly Past M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Marsel Mesulam M, Lipowski K, Kuo Wu C, Johnson N, Sadowsky C, Martinez W, Villena T, Scott Turner R, Johnson K, Reynolds B, Sperling R, Johnson K, Marshall G, Frey M, Yesavage J, Taylor J, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Sirrel S, Kowall N, Killiany R, Budson A, Norbash A, Lynn Johnson P, Obisesan T, Wolday S, Allard J, Lerner A, Ogrocki P, Hudson L, Fletcher E, Carmichael O, Olichney J, DeCarli C, Kittur S, Borrie M, Lee T, Bartha R, Johnson S, Asthana S, Carlsson C, G Potkin S, Preda A, Nguyen D, Tariot P, Reeder S, Bates V, Capote H, Rainka M, Scharre D, Kataki M, Adeli A, Zimmerman E, Celmins D, Brown A, Pearlson G, Blank K, Anderson K, Santulli R, Kitzmiller T, Schwartz E, SinkS K, Williamson J, Garg P, Watkins F, Ott B, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen H, Miller B, Mintzer J, Spicer K, Bachman D, Finger E, Pasternak S, Rachinsky I, Drost D, Pomara N, Hernando R, Sarrael A, Schultz S, Boles Ponto L, Shim H, Elizabeth Smith K, Relkin N, Chaing G, Raudin L, Smith A, Fargher K, Ashok Raj B. Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease. JAMA Neurology 2023, 80: 969-979. PMID: 37523162, PMCID: PMC10391361, DOI: 10.1001/jamaneurol.2023.2338.Peer-Reviewed Original ResearchCerebrospinal fluid biomarker profilePositron emission tomographyBiomarker profilesMagnetic resonance imagingCSF ALumbar punctureTau-PETClinical implicationsFluorodeoxyglucose positron emission tomographyAmyloid positron emission tomographyWisconsin Alzheimer's Disease Research CenterGlobal cognitive outcomeRetrospective cohort studyTau-PET uptakeAlzheimer's Disease Research CenterPrognosis of individualsADNI cohortDisease Research CenterAlzheimer's Disease Neuroimaging Initiative (ADNI) cohortCohort studyReferral centerSecondary outcomesPrimary outcomeMulticenter studyDisease progressionImpact of COVID-19 on the gastrointestinal surgical oncology patient population
Bakkila B, Marks V, Kerekes D, Kunstman J, Salem R, Billingsley K, Ahuja N, Laurans M, Olino K, Khan S. Impact of COVID-19 on the gastrointestinal surgical oncology patient population. Heliyon 2023, 9: e18459. PMID: 37534012, PMCID: PMC10391949, DOI: 10.1016/j.heliyon.2023.e18459.Peer-Reviewed Original ResearchGI cancer surgeryPreoperative chemotherapyCancer surgerySurgical careCOVID-19 pandemicCOVID-19Tertiary referral centerOncology patient populationFirst COVID-19 waveGI cancer casesCOVID-19 burdenHigh COVID-19 burdenEmergency surgeryReferral centerCOVID-19 waveOncology visitsGastrointestinal cancerGI cancersPatient populationStudy criteriaCancer careTreatment characteristicsCancer casesCase volumePatientsMechanistic Implications of Cortical Superficial Siderosis in Patients With Mixed Location Intracerebral Hemorrhage and Cerebral Microbleeds
Das A, Gokcal E, Biffi A, Regenhardt R, Pasi M, Abramovitz Fouks A, Viswanathan A, Goldstein J, Schwamm L, Rosand J, Greenberg S, Gurol M. Mechanistic Implications of Cortical Superficial Siderosis in Patients With Mixed Location Intracerebral Hemorrhage and Cerebral Microbleeds. Neurology 2023, 101: e636-e644. PMID: 37290968, PMCID: PMC10424843, DOI: 10.1212/wnl.0000000000207476.Peer-Reviewed Original ResearchConceptsCortical superficial siderosisCerebral microbleedsSuperficial siderosisIntracerebral hemorrhageHypertensive end-organ damagePresence of CMBsCerebral small vessel diseaseAdjusted hazard ratioEnd-organ damageCoronary artery diseaseDeep cerebral microbleedsSmall vessel diseaseImaging-based classificationLogistic regression modelsICH survivorsProspective databaseHazard ratioReferral centerArtery diseaseConsecutive patientsVentricular hypertrophyVessel diseaseICH recurrenceWarrant confirmationICH riskOsteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center
Basiri M, Ghaffari M, Ruan J, Murugesan V, Kleytman N, Belinsky G, Akhavan A, Lischuk A, Guo L, Klinger K, Mistry P. Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center. ELife 2023, 12: e87537. PMID: 37249220, PMCID: PMC10317498, DOI: 10.7554/elife.87537.Peer-Reviewed Original ResearchConceptsEnzyme replacement therapySubstrate reduction therapyAvascular osteonecrosisTertiary referral centerGaucher diseaseReferral centerTreatment initiationGD patientsImiglucerase enzyme replacement therapyResidual disease activityAnti-drug antibodiesYears of treatmentType of therapyRare inborn errorMixed-effects logistic modelGD1 patientsSpleen statusDisease activityClinical outcomesRisk stratificationReplacement therapyIndependent correlatesMultiple therapiesReduction therapyHigh riskCutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study
del Mar Castro M, Rode J, Machado P, Llanos-Cuentas A, Hueb M, Cota G, Rojas I, Orobio Y, Sarmiento O, Rojas E, Quintero J, Pimentel M, Soto J, Suprien C, Alvarez F, Ramos A, dos Santos Arantes R, da Silva R, Arenas C, Vélez I, Lyra M, Saravia N, Arana B, Alexander N. Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study. PLOS Neglected Tropical Diseases 2023, 17: e0011029. PMID: 36689465, PMCID: PMC9894540, DOI: 10.1371/journal.pntd.0011029.Peer-Reviewed Original ResearchConceptsCollaborative retrospective studyRetrospective studyAdverse reactionsCutaneous leishmaniasisAge groupsMedian lesion diameterOverall cure rateOlder adult patientsMost adverse reactionsCutaneous leishmaniasis treatmentYears of ageMonotherapy regimenAdult patientsReferral centerLocal therapyPediatric populationClinical recordsCure rateCL patientsTherapeutic responseClinical trialsDisease presentationMedian numberMild intensityAntileishmanial treatment
2022
MDS-529 The Prognostic Value of the Endothelial Activation and Stress Index (EASIX) Score, Platelet-to-Lymphocyte Ratio (PLR), and Neutrophil-to-Lymphocyte (NLR) in Myelodysplastic Syndrome Patients in Jordan after Adjusting for IPSS-R Risk Groups
Alrawabdeh J, Alzu'bi M, Hamadneh Y, Odeh N, Alzyoud M, Awidi A, Magableh A, Alshorman A, Al-Fararjeh F, Aladily T, Zeidan A, Bawa'neh H. MDS-529 The Prognostic Value of the Endothelial Activation and Stress Index (EASIX) Score, Platelet-to-Lymphocyte Ratio (PLR), and Neutrophil-to-Lymphocyte (NLR) in Myelodysplastic Syndrome Patients in Jordan after Adjusting for IPSS-R Risk Groups. Clinical Lymphoma Myeloma & Leukemia 2022, 22: s321. DOI: 10.1016/s2152-2650(22)01428-8.Peer-Reviewed Original ResearchPlatelet-lymphocyte ratioNeutrophil-lymphocyte ratioEASIX scoreMyelodysplastic syndromeFisher's exact testMDS patientsExact testStress Index scoresMedian ageEndothelial activationPrognostic valueFemale ratioRisk groupsIndex scoreMDS/MPN patientsAvailable prognostic systemsMultivariable Cox regressionJordan University HospitalMyelodysplastic syndrome patientsReferral centerIndependent predictorsAML transformationLymphocyte ratioCox regressionUnfavorable prognosisTraumatic Brain Injury in Honduras: The Use of a Paper‑based Surveillance System to Characterize Injuries Patterns
Johnson E, Rodriguez C, Puyana J, Bonilla-Escobar F. Traumatic Brain Injury in Honduras: The Use of a Paper‑based Surveillance System to Characterize Injuries Patterns. International Journal Of Medical Students 2022, 10: 381-386. PMID: 37378001, PMCID: PMC10299781, DOI: 10.5195/ijms.2022.1384.Peer-Reviewed Original ResearchLow-middle income countriesTraumatic brain injuryEpidemiology of traumatic brain injuryInjury Surveillance SystemProspective data collection methodsInjury surveillance toolEmergency department visitsTraffic accidentsImpact of traumatic brain injuryCross sectional reviewBrain injuryMechanism of injuryMild traumatic brain injuryDepartment visitsPenetrating knife injuryRoad traffic accidentsReferral centerIncome countriesReferral hospitalTBI-related emergency department visitsFirearm injuriesScore medianSecondary to road traffic accidentsData collection methodsSurveillance systemP11.54.A Factors effecting early diagnosis in neurolymphomatosis
Egert A, Karschnia P, Huttner A, Baehring J, Kaulen L. P11.54.A Factors effecting early diagnosis in neurolymphomatosis. Neuro-Oncology 2022, 24: ii70-ii70. PMCID: PMC9443184, DOI: 10.1093/neuonc/noac174.243.Peer-Reviewed Original ResearchNon-Hodgkin lymphomaEarly diagnosisSymptom onsetPathological findingsDiffuse large B-cell lymphomaCase of neurolymphomatosisDiagnosis of neurolymphomatosisYale Cancer CenterTertiary referral centerFDG-PET imagingPeripheral nervous systemB-cell lymphomaImaging gold standardSPSS version 27Painful polyneuropathyPainless polyneuropathySecondary neurolymphomatosisAutonomic neuropathyCranial neuropathiesMedian intervalReferral centerAutonomic nervesClinical suspicionFDG-PETCancer CenterClinical and neuroimaging risk factors associated with the development of intracerebral hemorrhage while taking direct oral anticoagulants
Das A, Gökçal E, Regenhardt R, Warren A, Biffi A, Goldstein J, Kimberly W, Viswanathan A, Schwamm L, Rosand J, Greenberg S, Gurol M. Clinical and neuroimaging risk factors associated with the development of intracerebral hemorrhage while taking direct oral anticoagulants. Journal Of Neurology 2022, 269: 6589-6596. PMID: 35997817, PMCID: PMC10947801, DOI: 10.1007/s00415-022-11333-2.Peer-Reviewed Original ResearchConceptsCortical superficial siderosisPrior ischemic strokeDOAC usersCerebral microbleedsWhite matter hyperintensitiesIschemic strokeSevere white matter hyperintensitiesOral anticoagulant usageDirect oral anticoagulantsSingle referral centerHigh hemorrhagic riskCoronary artery diseaseAge-matched controlsMultivariable regression modelsDOAC therapyICH cohortPrior strokeOral anticoagulantsSuperficial siderosisBaseline demographicsReferral centerSmoking historyArtery diseaseConclusionsRisk factorsHemorrhage riskPractical considerations and consensus opinion for children’s hospital–based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis
Woods GM, Raffini L, Brandão LR, Jaffray J, Branchford BR, Ng CJ, Sartain SE, Pak J, Male C, Zia A, Rizzi M, Sirachainan N, Faustino E, Carpenter SL, Goldenberg NA. Practical considerations and consensus opinion for children’s hospital–based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis. Journal Of Thrombosis And Haemostasis 2022, 20: 2151-2158. PMID: 35748322, DOI: 10.1111/jth.15798.Peer-Reviewed Original ResearchConceptsTertiary care referral centerConsensus opinionAnticoagulation management serviceManagement of patientsNumerous therapeutic advancesDisorders of hemostasisISTH SSC SubcommitteeNeonatal thrombosisFellowship training programsInpatient managementReferral centerAdult hospitalsPediatric institutionTherapeutic advancesPediatric dataHAT patientsMedical complexityInpatient settingThrombosisHemostasisConsultative servicesPatientsTraining programCurrent practiceComplicationsKetamine Boluses Are Associated with a Reduction in Intracranial Pressure and an Increase in Cerebral Perfusion Pressure: A Retrospective Observational Study of Patients with Severe Traumatic Brain Injury
Dengler BA, Karam O, Barthol CA, Chance A, Snider LE, Mundy CM, Bounajem MT, Johnson WC, Maita MM, Mendez-Gomez PM, Seifi A, Hafeez S. Ketamine Boluses Are Associated with a Reduction in Intracranial Pressure and an Increase in Cerebral Perfusion Pressure: A Retrospective Observational Study of Patients with Severe Traumatic Brain Injury. Critical Care Research And Practice 2022, 2022: 3834165. PMID: 35637760, PMCID: PMC9148235, DOI: 10.1155/2022/3834165.Peer-Reviewed Original ResearchCerebral perfusion pressureSevere traumatic brain injuryTraumatic brain injuryKetamine bolusGlasgow Coma ScaleRefractory intracranial pressureIntracranial pressureBrain injuryPerfusion pressureRetrospective reviewSingle tertiary referral centerTraumatic brain injury populationSustained ICPTertiary referral centerNeurointensive care unitRetrospective observational studyBolus of ketamineSingle-institution studyBrain injury populationIntracranial pressure monitorSystemic hypotensionReferral centerSedative medicationsAdequate sedationComa Scale
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply